PAVE Act

HR 5736, the PAVE Act, requires Medicare beneficiaries aged 65 and older to receive penicillin allergy verification during their initial preventive physical exam and annual wellness visit. The bill mandates that healthcare providers identify patients reporting a penicillin allergy, evaluate whether the reported reaction was a true allergy, explain the health risks of a false allergy label, and refer to specialists when needed. This verification process, effective January 2027, aims to correct false allergy labels - over 90% of which are inaccurate - improving antibiotic choices and patient outcomes. It directly affects seniors covered by Medicare who have self-reported penicillin allergies, with no cost to patients for this service.